Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2014, Vol. 19 ›› Issue (4): 419-423.

Previous Articles     Next Articles

Pharmacokinetics of fosphenytoin sodium injection in Chinese healthy volunteers

HUANG Xiao-yan1, GUO Xin2, YU Peng1, LIU Zhi2, HUANG Zhi-jun3, YANG Guo-ping3, CHENG Ze-neng1   

  1. 1Research Institute of Drug Metabolism and Pharmacokinetics, School of Pharmaceutical Science, Central South University,
    2Hunan Tiger Xiangya R&D Co., Ltd,
    3Clinical Pharmacy & pharmacology Institute, Third Xiang Ya Hospital, Central South University, Changsha 410013, Hunan, China
  • Received:2013-09-23 Revised:2014-03-19 Online:2014-04-26 Published:2020-07-24

Abstract: AIM: To investigate the pharmacokinetics of fosphenytoin sodium injection at single dose in Chinese healthy volunteers. METHODS: The pharmacokinetics of intravenous infusing fosphenytoin sodium injection at different dose levels (600 mg and 900 mg) was studied in 24 healthy volunteers.The drug concentrations in plasma samples were assayed by HPLC, and the pharmacokinetic parameters were calculated by DAS 2.0 software. RESULTS: Among 24 healthy subjects, the main pharmacokinetic parameters of fosphenytoin after single dose of 600 mg and 900 mg were as follows: Cmax were (89.3±14.9), (110.5±17.2) mg/L; tmax were (0.46±0.08), (0.46±0.08) h; AUC0-t were (56.5±11.3), (71.2±13.8) mg·h·L-1; for phenytoin, they were Cmax (8.36±0.92), (11.98±1.07) mg/L; tmax (1.1±0.3), (1.3±0.3) h; AUC0-t(222.7±47.8), (355.9±72.6) mg·h·L-1, respectively. CONCLUSION: After 600-900 mg single dose infusion of fosphenytoin sodium injection, the pharmacokinetic results show that both fosphenytoin and phenytoin exhibit first order kinetic characteristics in such a dose. And the pharmacokinetic characteristics of fosphenytoin sodium injection are consistent with foreign reports.

Key words: fosphenytoin, pharmacokinetics, HPLC

CLC Number: